Nanoparticles disguised as red blood cells; Depomed alleges patent infringement against Sun;

> Nanoparticles disguised as red blood cells deliver cancer-fighting drugs. More here

> Depomed has filed a patent infringement lawsuit against Sun Pharmaceutical Industries, alleging Sun intends to market generic Glumetza (metformin hydrochloride extended release tablets) before the expiration of Depomed's patents. Release

> To bypass the blood-brain barrier, drugs can be delivered through the nose to target the brain, says a researcher in Egypt. Report

> Could remote drug delivery gadgets be hacked? Blog post

> Pulmatrix introduces inhaled dry powder drug delivery platform iSPERSE. Story

And Finally... Futura Medical's "erection enhancing" condom CSD500, which "incorporates an erectogenic compound" to help men stay firmer during intercourse, has been recommended for European approval. The big story

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.